CSTE/CDC multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2 infection surveillance interim case reporting guide

Details

• Corporate Authors:
  National Center for Immunization and Respiratory Diseases (U.S.) ; Council of State and Territorial Epidemiologists.
• Content Notes:
  Updated 11/7/22
  
  The purpose of this document is to assist local, state, and territorial health departments with reporting cases of MIS-C to CDC after the new CSTE/CDC MIS-C surveillance case definition has gone into effect on January 1, 2023. This guide is to be used for cases that are reported to CDC after January 1, 2023 but have an MIS-C illness onset before January 1, 2023. These potential MIS-C illnesses should be adjudicated as MIS-C cases using the 2020 CDC MIS-C case definition but submitted to CDC using the new CSTE/CDC MIS-C surveillance case definition report form. The following table provides detailed guidance on how to adjudicate using the 2020 CDC case definition while reporting with the CSTE/CDC case report form.
  
  mis-c_interim-case-reporting-guidance.pdf
  
  
• Subjects:
  Child Coronavirus Infections COVID-19/complications Inflammation Systemic Inflammatory Response Syndrome
• Document Type:
  Pamphlet (or booklet)
• Genre:
  Fact Sheet
• Pages in Document:
  4 numbered pages
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha256:0d23af186d039f99f71f3e4325bc9912c0e13d6116f094e71e303822cd83df14
• Download URL:
  https://stacks.cdc.gov/view/cdc/122831/cdc_122831_DS1.pdf
• File Type:
  [PDF - 180.92 KB ]